MAPT and supranuclear palsy, progressive, 1: It would be intriguing to speculate that the reduction of STX6 expression specifically in white matter associated with PSP risk could be a contributor to the characteristic white matter involvement in PSP, including oligodendroglial tau pathology and/or myelination defects because of impairments in intracellular protein triage and transportation.